Literature DB >> 25448150

Using cost-effective intra-arterial chemotherapy to treat retinoblastoma in Chile.

Diego Ossandón1, Mario Zanolli2, Verónica Pérez3, Paulo Zúñiga4, Álvaro Belmar4, Mónica Varas3, Carol L Shields5.   

Abstract

Intra-arterial chemotherapy (IAC) has proved to be an effective treatment for retinoblastoma, but can be very expensive in developing countries. We report 2 patients from Chile in whom IAC resulted in globe salvation. Both patients had their medical care provided by the public health system and had failed standard therapy.
Copyright © 2014 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25448150     DOI: 10.1016/j.jaapos.2014.07.170

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  3 in total

1.  Prevalence of refractive errors in children with retinoblastoma.

Authors:  Victor M Villegas; Shuo-Chieh Wu; Timothy G Murray; Kara M Cavuoto; Hilda Capo; Craig A McKeown
Journal:  Clin Ophthalmol       Date:  2019-02-25

2.  Intra-arterial chemotherapy for retinoblastoma: Our first experience in Indonesia.

Authors:  Prijo Sidipratomo; Jacub Pandelaki; Sahat B R E Matondang; Heltara Ramandika; Rita Sita Sitorus; Komang S Karismaputri
Journal:  Radiol Case Rep       Date:  2022-10-02

3.  Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras.

Authors:  David A Camp; Lauren A Dalvin; Rachel Schwendeman; Li-Anne S Lim; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.